Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study

BACKGROUND: There are limited treatment options for patients with metastatic nasopharyngeal carcinoma (mNPC) after failure of platinum-based chemotherapy. In this trial, we assessed the efficacy and safety of sintilimab plus bevacizumab in patients with mNPC where platinum-based chemotherapy has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Nian, Jiang, Yao-Fei, Xia, Wei-Xiong, Huang, Ying, Xie, Chuan-Miao, Xu, Cheng, Ye, Yan-Fang, Liu, Guo-Ying, Bei, Wei-Xin, Ke, Liang-Ru, Li, Wang-Zhong, Zhang, Cheng, Wang, Xin, Liu, Qin, Chen, Xi, Chen, Zi-Xiong, Xie, Changqing, Liang, Hu, Xiang, Yan-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430191/
https://www.ncbi.nlm.nih.gov/pubmed/37593221
http://dx.doi.org/10.1016/j.eclinm.2023.102136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430191/
https://www.ncbi.nlm.nih.gov/pubmed/37593221
http://dx.doi.org/10.1016/j.eclinm.2023.102136

Ejemplares similares